BWIS,
The question I posed is somewhat rhetorical as I believe that Kat’s Cure and Mr. Power represented only 2 potential opportunities for NWBO and INMune Bio to team up with a combo type of treatment outside of the Phase 3 trial because of the gravity of their situations. I believe there was a 2 for 2 cure rate with this combo tech. Care to try and estimate a value on that and maybe comment on why you would want to keep that quiet while you can still maintain control of the company? In my opinion Linda Powers has unbelievable leverage right now as long as what she has in her hands is under appreciated because no one knows except a very select group and longs aren’t selling out cheap but would be tempted to by any rise after TLD. I believe Kristin Power will act as Canadian liaison for patients, doctors and potential investors and that location is not as important as skill set, knowledge and enthusiasm. Best wishes
Market Data 
Markets 
AI
